128 related articles for article (PubMed ID: 17895813)
1. Intravitreal triamcinolone or bevacizumab for nonarteritic anterior ischemic optic neuropathy: do they merit further study?
Kelman SE
J Neuroophthalmol; 2007 Sep; 27(3):161-3. PubMed ID: 17895813
[No Abstract] [Full Text] [Related]
2. Intravitreal triamcinolone improves recovery of visual acuity in nonarteritic anterior ischemic optic neuropathy.
Kaderli B; Avci R; Yucel A; Guler K; Gelisken O
J Neuroophthalmol; 2007 Sep; 27(3):164-8. PubMed ID: 17895814
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal triamcinolone for nonarteritic anterior ischemic optic neuropathy.
Hayreh SS
J Neuroophthalmol; 2008 Mar; 28(1):77-8; author reply 78-9. PubMed ID: 18347467
[No Abstract] [Full Text] [Related]
4. Treatment of nonarteritic anterior ischemic optic neuropathy with intravitreal bevacizumab.
Bennett JL; Thomas S; Olson JL; Mandava N
J Neuroophthalmol; 2007 Sep; 27(3):238-40. PubMed ID: 17895825
[No Abstract] [Full Text] [Related]
5. [Intravitreal triamcinolone and bevacizumab injections for alternative treatment of nanophthalmic uveal effusion syndrome].
Rüfer F; Varde MA; Roider J
Klin Monbl Augenheilkd; 2008 Jun; 225(6):594-6. PubMed ID: 18516783
[No Abstract] [Full Text] [Related]
6. Intravitreal injection: balancing the risks.
Chong NV; Adewoyin T
Eye (Lond); 2007 Mar; 21(3):313-6. PubMed ID: 17330108
[No Abstract] [Full Text] [Related]
7. Anterior ischemic optic neuropathy.
Entezari M; Ramezani A; Pakravan M; Mahmoodi A; Hassanpour H; Yaseri M
Ophthalmology; 2012 Apr; 119(4):879-80. PubMed ID: 22472252
[No Abstract] [Full Text] [Related]
8. Is intravitreal bevacizumab an effective treatment option for nonarteritic anterior ischemic optic neuropathy?
Prescott CR; Sklar CA; Lesser RL; Adelman RA
J Neuroophthalmol; 2012 Mar; 32(1):51-3. PubMed ID: 22269947
[TBL] [Abstract][Full Text] [Related]
9. Anterior ischemic optic neuropathy after intravitreal injection of bevacizumab.
Hosseini H; Razeghinejad MR
J Neuroophthalmol; 2009 Jun; 29(2):160-1. PubMed ID: 19491650
[No Abstract] [Full Text] [Related]
10. Intravitreal triamcinolone and bevacizumab combination therapy for macular edema due to central retinal vein occlusion refractory to either treatment alone.
Ekdawi NS; Bakri SJ
Eye (Lond); 2007 Aug; 21(8):1128-30. PubMed ID: 17585312
[No Abstract] [Full Text] [Related]
11. Intravitreal ranibizumab injection for nonarteritic ischemic optic neuropathy.
Pece A; Querques G; Quinto A; Isola V
J Ocul Pharmacol Ther; 2010 Oct; 26(5):523-7. PubMed ID: 20874667
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal bevacizumab with or without triamcinolone for refractory diabetic macular oedema.
Synek S; Vojniković B
Coll Antropol; 2010 Apr; 34 Suppl 2():99-103. PubMed ID: 21305729
[TBL] [Abstract][Full Text] [Related]
13. Diffuse diabetic macular oedema treated with intravitreal bevacizumab or triamcinolone acetonide.
Rensch F; Spandau UH; Wickenhäuser A; Jonas JB
Acta Ophthalmol; 2010 Mar; 88(2):e36-7. PubMed ID: 19210330
[No Abstract] [Full Text] [Related]
14. Intravitreal bevacizumab for the treatment of nonarteritic anterior ischemic optic neuropathy: a prospective trial.
Rootman DB; Gill HS; Margolin EA
Eye (Lond); 2013 Apr; 27(4):538-44. PubMed ID: 23370417
[TBL] [Abstract][Full Text] [Related]
15. Combined intravitreal bevacizumab and triamcinolone acetonide injection for idiopathic neuroretinitis.
Cakir M; Cekiç O; Bozkurt E; Pekel G; Yazici AT; Yilmaz OF
Ocul Immunol Inflamm; 2009; 17(3):221-3. PubMed ID: 19585368
[TBL] [Abstract][Full Text] [Related]
16. Non-arteritic ischemic optic neuropathy followed by intravitreal bevacizumab injection: is there an association?
Bodla AA; Rao P
Indian J Ophthalmol; 2010; 58(4):349-50. PubMed ID: 20534939
[No Abstract] [Full Text] [Related]
17. Intravitreal bevacizumab vs triamcinolone acetonide for macular oedema due to central retinal vein occlusion.
Hu YJ
Eye (Lond); 2010 Aug; 24(8):1414; author reply 1414-5. PubMed ID: 20339391
[No Abstract] [Full Text] [Related]
18. Intravitreal bevacizumab vs triamcinolone acetonide for macular oedema due to central retinal vein occlusion.
Tao Y; Hou J; Jiang YR; Li XX; Jonas JB
Eye (Lond); 2010 May; 24(5):810-5. PubMed ID: 19696805
[TBL] [Abstract][Full Text] [Related]
19. [Exsudative AMD: Regression analysis of transpupillary thermotherapy with and without intravitreal injection of triamcinolone, bevacizumab and ranibizumab].
Weber U
Klin Monbl Augenheilkd; 2010 Nov; 227(11):897-904. PubMed ID: 20640976
[TBL] [Abstract][Full Text] [Related]
20. Single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration.
Ahmadieh H; Taei R; Soheilian M; Riazi-Esfahani M; Karkhaneh R; Lashay A; Azarmina M; Dehghan MH; Moradian S
BMC Ophthalmol; 2007 Jun; 7():10. PubMed ID: 17555600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
